Fehske KJ[au] - Search Results

Year	Number of Results
1978	2
1979	2
1980	3
1981	5
1982	4
1984	2
1985	1
1986	1
1990	1
2024	0

1

The location of drug binding sites in human serum albumin.

Fehske KJ, Müller WE, Wollert U. Fehske KJ, et al. Biochem Pharmacol. 1981 Apr 1;30(7):687-92. doi: 10.1016/0006-2952(81)90151-9. Biochem Pharmacol. 1981. PMID: 7018498 Review. No abstract available.

2

On the neuropharmacology of harmane and other beta-carbolines.

Müller WE, Fehske KJ, Borbe HO, Wollert U, Nanz C, Rommelspacher H. Müller WE, et al. Among authors: fehske kj. Pharmacol Biochem Behav. 1981 May;14(5):693-9. doi: 10.1016/0091-3057(81)90133-7. Pharmacol Biochem Behav. 1981. PMID: 6264501 No abstract available.

3

Azapropazone binding to human serum albumin.

Fehske KJ, Jähnchen E, Müller WE, Stillbauer A. Fehske KJ, et al. Naunyn Schmiedebergs Arch Pharmacol. 1980 Aug;313(2):159-63. doi: 10.1007/BF00498574. Naunyn Schmiedebergs Arch Pharmacol. 1980. PMID: 7422015

4

Benzodiazepine antagonism by harmane and other beta-carbolines in vitro and in vivo.

Rommelspacher H, Nanz C, Borbe HO, Fehske KJ, Müller WE, Wollert U. Rommelspacher H, et al. Among authors: fehske kj. Eur J Pharmacol. 1981 Mar 26;70(3):409-16. doi: 10.1016/0014-2999(81)90173-4. Eur J Pharmacol. 1981. PMID: 6112154

5

The demonstration of several neurotransmitter and drug receptors in human retina.

Borbe HO, Fehske KJ, Müller WE, Nover A, Woller U. Borbe HO, et al. Among authors: fehske kj. Comp Biochem Physiol C Comp Pharmacol. 1982;72(1):117-9. doi: 10.1016/0306-4492(82)90215-5. Comp Biochem Physiol C Comp Pharmacol. 1982. PMID: 6125322 No abstract available.

6

Acute and chronic effects of a diuretic monotherapy with piretanide in congestive heart failure--a placebo-controlled trial.

Haerer W, Bauer U, Sultan N, Cernoch K, Mouselimis N, Fehske KJ, Hetzel M, Stauch M, Hombach V. Haerer W, et al. Among authors: fehske kj. Cardiovasc Drugs Ther. 1990 Apr;4(2):515-21. doi: 10.1007/BF01857763. Cardiovasc Drugs Ther. 1990. PMID: 2285635 Clinical Trial.

7

1-Methyl-beta-carboline (harmane), a potent endogenous inhibitor of benzodiazepine receptor binding.

Rommelspacher H, Nanz C, Borbe HO, Fehske KJ, Müller WE, Wollert U. Rommelspacher H, et al. Among authors: fehske kj. Naunyn Schmiedebergs Arch Pharmacol. 1980 Oct;314(1):97-100. doi: 10.1007/BF00498436. Naunyn Schmiedebergs Arch Pharmacol. 1980. PMID: 6255348

8

Competition between drugs and nutrients for specific ligand binding sites on human serum albumin.

Kiem E, Fehske KJ, Müller WE. Kiem E, et al. Among authors: fehske kj. World Rev Nutr Diet. 1984;43:179-82. doi: 10.1159/000409070. World Rev Nutr Diet. 1984. PMID: 6475096 No abstract available.

9

High-affinity binding of ethacrynic acid is mediated by the two most important drug binding sites of human serum albumin.

Fehske KJ, Müller WE. Fehske KJ, et al. Pharmacology. 1986;32(4):208-13. doi: 10.1159/000138171. Pharmacology. 1986. PMID: 3714803

10

Beta-carboline binding indicates the presence of benzodiazepine receptor subclasses in the bovine central nervous system.

Fehske KJ, Zube I, Borbe HO, Wollert U, Müller WE. Fehske KJ, et al. Naunyn Schmiedebergs Arch Pharmacol. 1982 May;319(2):172-7. doi: 10.1007/BF00503933. Naunyn Schmiedebergs Arch Pharmacol. 1982. PMID: 6287307

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

21 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year